chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache, Nausea, Pain, Rash
Clinical narrative: 1/31/23 started with headache, nausea, body aches 2/1 full body rash  took benadryl 2/1 rash still present will continue antihistamine treatment
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Bacterial test, Blood culture negative, Blood lactic acid decreased, COVID-19, Chest X-ray abnormal
Clinical narrative: Patient is a 84 y.o. male patient of MD with history of Afib, HTN, CKD, Alzheimer's dementia currently at rehab facility presented to Hospital with altered mentation and elevated HR. found to be septic due to viral etiology most likely with COVID positive status.  He remained on room air throughout hospitalization and therefore not a candidate for most therapies and not a candidate for others due to renal function.  General surgery consulted to evaluate diverticulitis.  Although likely not the underlying cause of sepsis was placed on course of antibiotics.  MRI showed no stroke but did reveal likely NPH, from discussion with wife this appears to be a chronic process.  Neuro  Sepsis  Likely due to COVID infection, diverticulitis with possible contribution of aspiration pneumonia CT with findings concerning for aspiration pneumonitis Afebrile, WBC 18k , LA 2.5 on admission UA trace LE, few WBCs, rare bact  CXR without new focal consolidation or infiltrate  Urine culture with no growth Blood culture 1/2 positive coag negative staph, likely contaminant Repeat blood cultures: NGTD Lactic acidosis and leukocytosis resolved de-escalate to cipro/flagyl  No current surgical indication for surgery, plan for 10-14 days of Cipro/Flagyl   Covid-19 Virus Infection Date of onset of symptoms: 1/8 Symptoms present on admission: Altered mental status, fatigue Date of covid positive test: 1/9 Imaging: Chest x-ray: Emphysematous changes, no new focal consolidation Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: not indicated as not hypoxic also not a candidate for paxlovid due to renal function  Anticipated special isolation end date: 10/19
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Culture urine negative, Diverticulitis, Emphysema, Fatigue
Clinical narrative: Patient is a 84 y.o. male patient of MD with history of Afib, HTN, CKD, Alzheimer's dementia currently at rehab facility presented to Hospital with altered mentation and elevated HR. found to be septic due to viral etiology most likely with COVID positive status.  He remained on room air throughout hospitalization and therefore not a candidate for most therapies and not a candidate for others due to renal function.  General surgery consulted to evaluate diverticulitis.  Although likely not the underlying cause of sepsis was placed on course of antibiotics.  MRI showed no stroke but did reveal likely NPH, from discussion with wife this appears to be a chronic process.  Neuro  Sepsis  Likely due to COVID infection, diverticulitis with possible contribution of aspiration pneumonia CT with findings concerning for aspiration pneumonitis Afebrile, WBC 18k , LA 2.5 on admission UA trace LE, few WBCs, rare bact  CXR without new focal consolidation or infiltrate  Urine culture with no growth Blood culture 1/2 positive coag negative staph, likely contaminant Repeat blood cultures: NGTD Lactic acidosis and leukocytosis resolved de-escalate to cipro/flagyl  No current surgical indication for surgery, plan for 10-14 days of Cipro/Flagyl   Covid-19 Virus Infection Date of onset of symptoms: 1/8 Symptoms present on admission: Altered mental status, fatigue Date of covid positive test: 1/9 Imaging: Chest x-ray: Emphysematous changes, no new focal consolidation Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: not indicated as not hypoxic also not a candidate for paxlovid due to renal function  Anticipated special isolation end date: 10/19
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased, Lactic acidosis, Leukocytosis, Lung infiltration, Magnetic resonance imaging head abnormal
Clinical narrative: Patient is a 84 y.o. male patient of MD with history of Afib, HTN, CKD, Alzheimer's dementia currently at rehab facility presented to Hospital with altered mentation and elevated HR. found to be septic due to viral etiology most likely with COVID positive status.  He remained on room air throughout hospitalization and therefore not a candidate for most therapies and not a candidate for others due to renal function.  General surgery consulted to evaluate diverticulitis.  Although likely not the underlying cause of sepsis was placed on course of antibiotics.  MRI showed no stroke but did reveal likely NPH, from discussion with wife this appears to be a chronic process.  Neuro  Sepsis  Likely due to COVID infection, diverticulitis with possible contribution of aspiration pneumonia CT with findings concerning for aspiration pneumonitis Afebrile, WBC 18k , LA 2.5 on admission UA trace LE, few WBCs, rare bact  CXR without new focal consolidation or infiltrate  Urine culture with no growth Blood culture 1/2 positive coag negative staph, likely contaminant Repeat blood cultures: NGTD Lactic acidosis and leukocytosis resolved de-escalate to cipro/flagyl  No current surgical indication for surgery, plan for 10-14 days of Cipro/Flagyl   Covid-19 Virus Infection Date of onset of symptoms: 1/8 Symptoms present on admission: Altered mental status, fatigue Date of covid positive test: 1/9 Imaging: Chest x-ray: Emphysematous changes, no new focal consolidation Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: not indicated as not hypoxic also not a candidate for paxlovid due to renal function  Anticipated special isolation end date: 10/19
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Mental status changes, Normal pressure hydrocephalus, SARS-CoV-2 test positive, Sepsis, Staphylococcus test negative
Clinical narrative: Patient is a 84 y.o. male patient of MD with history of Afib, HTN, CKD, Alzheimer's dementia currently at rehab facility presented to Hospital with altered mentation and elevated HR. found to be septic due to viral etiology most likely with COVID positive status.  He remained on room air throughout hospitalization and therefore not a candidate for most therapies and not a candidate for others due to renal function.  General surgery consulted to evaluate diverticulitis.  Although likely not the underlying cause of sepsis was placed on course of antibiotics.  MRI showed no stroke but did reveal likely NPH, from discussion with wife this appears to be a chronic process.  Neuro  Sepsis  Likely due to COVID infection, diverticulitis with possible contribution of aspiration pneumonia CT with findings concerning for aspiration pneumonitis Afebrile, WBC 18k , LA 2.5 on admission UA trace LE, few WBCs, rare bact  CXR without new focal consolidation or infiltrate  Urine culture with no growth Blood culture 1/2 positive coag negative staph, likely contaminant Repeat blood cultures: NGTD Lactic acidosis and leukocytosis resolved de-escalate to cipro/flagyl  No current surgical indication for surgery, plan for 10-14 days of Cipro/Flagyl   Covid-19 Virus Infection Date of onset of symptoms: 1/8 Symptoms present on admission: Altered mental status, fatigue Date of covid positive test: 1/9 Imaging: Chest x-ray: Emphysematous changes, no new focal consolidation Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: not indicated as not hypoxic also not a candidate for paxlovid due to renal function  Anticipated special isolation end date: 10/19
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Urine leukocyte esterase positive, White blood cell count increased, White blood cells urine positive
Clinical narrative: Patient is a 84 y.o. male patient of MD with history of Afib, HTN, CKD, Alzheimer's dementia currently at rehab facility presented to Hospital with altered mentation and elevated HR. found to be septic due to viral etiology most likely with COVID positive status.  He remained on room air throughout hospitalization and therefore not a candidate for most therapies and not a candidate for others due to renal function.  General surgery consulted to evaluate diverticulitis.  Although likely not the underlying cause of sepsis was placed on course of antibiotics.  MRI showed no stroke but did reveal likely NPH, from discussion with wife this appears to be a chronic process.  Neuro  Sepsis  Likely due to COVID infection, diverticulitis with possible contribution of aspiration pneumonia CT with findings concerning for aspiration pneumonitis Afebrile, WBC 18k , LA 2.5 on admission UA trace LE, few WBCs, rare bact  CXR without new focal consolidation or infiltrate  Urine culture with no growth Blood culture 1/2 positive coag negative staph, likely contaminant Repeat blood cultures: NGTD Lactic acidosis and leukocytosis resolved de-escalate to cipro/flagyl  No current surgical indication for surgery, plan for 10-14 days of Cipro/Flagyl   Covid-19 Virus Infection Date of onset of symptoms: 1/8 Symptoms present on admission: Altered mental status, fatigue Date of covid positive test: 1/9 Imaging: Chest x-ray: Emphysematous changes, no new focal consolidation Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: not indicated as not hypoxic also not a candidate for paxlovid due to renal function  Anticipated special isolation end date: 10/19
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: Moderna Bivalent given unnecessarily.  Patient had already been given this dose on 11/8/2022.
Age: 60.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Chest X-ray abnormal, Dizziness, Dyspnoea, Feeling abnormal, Nasopharyngitis
Clinical narrative: After the November holiday I came down with seemed liked a head cold. I was having runny nose sore throat and sinus congestion. I took two COVID-19 test, and they both came back as negative. I suffered this feeling all through December. It was just a constant cold; it took a turn for the worse on December 28. I was having difficulty breathing at that point. I could not get rid of it. I contacted my doctor on 01/03/2023. He listened to my lungs, and it showed congestion. I was sent for a X-ray. Now I am feeling not great still having the same symptoms with now dizziness. I had two rounds of antibiotics and I saw him last on 01/26/2023. He says if I'm seeing improvement, I need to see him on this Friday. I have Pneumonia.
Age: 60.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Oropharyngeal pain, Pneumonia, Respiratory tract congestion, Rhinorrhoea, Sinus congestion
Clinical narrative: After the November holiday I came down with seemed liked a head cold. I was having runny nose sore throat and sinus congestion. I took two COVID-19 test, and they both came back as negative. I suffered this feeling all through December. It was just a constant cold; it took a turn for the worse on December 28. I was having difficulty breathing at that point. I could not get rid of it. I contacted my doctor on 01/03/2023. He listened to my lungs, and it showed congestion. I was sent for a X-ray. Now I am feeling not great still having the same symptoms with now dizziness. I had two rounds of antibiotics and I saw him last on 01/26/2023. He says if I'm seeing improvement, I need to see him on this Friday. I have Pneumonia.
Age: 11.0
Sex: F
Vaccine: COVID19-2, FLU4, MNQ
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received the Pfizer Bivalent vaccine without receiving the primary monovalent series.
Age: 33.0
Sex: F
Vaccine: HPV9
Symptoms: Arthralgia, Limb mass, Tenderness
Clinical narrative: 2 weeks after injection patient developed a sore shoulder. Then noticed a lump. It is tender to the touch, but not tender otherwise. Denies signs of infection.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: where a patient DID develop shingles after receiving SHINGRIX shot(s). /Suspected vaccination failure; where a patient DID develop shingles after receiving SHINGRIX shot(s).; This case was reported by a nurse via call center representative and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix.     Additional Information: GSK Receipt Date: 26-JAN-2023 Reporter's comments: The female pharmacist had stated that she had seen a case sometime in the past where a patient did have developed shingles after receiving Shingrix shot(s). The reporter did not remember if the pharmacist used the male pronoun or the female pronoun when discussing this patient (and did not know if the patient in question received only one or both of the Shingrix shots). The reporter did provide the pharmacy name and phone number where the female pharmacist works and where this conversation had occurred.  The reporter did not know the name of the pharmacist. No further details provided.  The reporter had consented to follow-up. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.  This case US2023011716 was not linked with US2023AMR011584 based on the response received from the hub.
Sex: M
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: 1st dose 30Nov2019. 2nd not yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 91-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 30th November 2019).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 26 Jan 2023 Reporters comment: The case was reported by the pharmacist. The pharmacist reported that the patient received the first dose of Shingrix on 30th November 2019 and then patient did not receive the second dose. The reporter asked if they could administer the second dose or if the patient had to start over with the vaccination schedule.  The reporter consented to follow up. Additional supportive information: Till the time of reporting the patient did not received the 2nd dose of vaccine which led to incomplete course of vaccination.
Age: 67.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: shingles after months of 2nd dose / Suspected vaccination failure; Shingles; This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included bone marrow transplant and leukemia.   On 30th August 2022, the patient received the 2nd dose of Shingrix. On 8th June 2022, the patient received the 1st dose of Shingrix. On 22nd January 2023, 145 days after receiving Shingrix and 228 days after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The patient was treated with valaciclovir (Valacyclovir) and hydrocortisone. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.     Additional Information: GSK receipt date :27 Jan 2023 Reporters comment: The reporter is patient's wife. The reporter stated that the patient received 1st dose on 30th August 2022 and 2nd dose on 6th June 2022 and developed shingles on 22nd January 2023. The patient has been started on Valacyclovir and a hydrocortisone cream for treatment. The Reporter consented to follow up. Additional supportive information: This case was considered as suspected vaccination failure as details regarding laboratory test confirming shingles were unknown at the time of reporting. Reporter consented to follow up.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Drug ineffective, Herpes zoster, Incomplete course of vaccination
Clinical narrative: Shingles 2 years after 1st dose; Forgot to get her second dose; This case was reported by a consumer via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and did not receive the 2nd dose of Shingrix. On an unknown date, 2 years after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles and incomplete course of vaccination. On an unknown date, the outcome of the shingles and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.     Additional Information: GSK Receipt Date: 30-JAN-2023 Reporter's Comment: The case was self reported by the patient. The patient only had one dose of Shingrix and reported that she forgot to get her second dose of Shingrix. (lack of effect-missed dose). The patient received first dose of Shingrix and two years after vaccination with first dose she was diagnosed with shingles and stated that the vaccination and having the shingles were worst experiences she ever had. The patient reported that she advocated for others to get vaccinated with Shingrix. Limited information available from reporter. The reporter declined to give consent or any demographic information. The reporter did not consent to follow up. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Incorrect dose administered, Incorrect product formulation administered
Clinical narrative: Second monovalent dose was given per patient's information given, but patient had neglected to tell nursing staff he had already had received a second monovalent injection. So wrong dose and given too early. Should have been a bivalent given in two months.
Age: 37.0
Sex: M
Vaccine: COVID19-2, HEPA
Symptoms: Depression, Feeling abnormal
Clinical narrative: I started to have really bad depression. After about 2 and a half weeks, I went to see the doctor. She did not provide any treatment. She told me to go to see my PCP I scheduled an appointment with my primary care doctor. I am still feeling low, and nothing makes sense. I am still having the same feelings.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vial of Pfizer Bivalent Covid vaccine had been opened for more than the recommended 12 hours after opening, and a dose was administered 2/1/23. Notified immunization supervisor, awaiting further recommendations from immunizations coordinator from our State Authorities.
Age: 1.0
Sex: M
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: On 01/24/2023 the clinic staff realized that the ProQuad vaccine was being stored improperly.  The vaccine was stored in the fridge instead of the vaccine freezer.  This patient was identified as having received a dose of the vaccine that was stored improperly.  The patient will be brought back to clinic to request the ProQuad.  No adverse reactions from the initial vaccine were reported to the clinic.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Blood test, Confusional state, Depressed level of consciousness, Lumbar puncture, Meningitis
Clinical narrative: Pt was given his vaccines at his 11 year WCC and was admitted to the hospital on 9/13 due to decreased LOC, confusion, was hospitalized for almost 2 weeks and diagnosed with meningitis but the cause was never discovered
Age: 5.0
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: injection site redness and rash
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Chest X-ray, Coagulation test, Computerised tomogram abnormal, Deep vein thrombosis
Clinical narrative: Developed shortness of breath  and low oxygen saturation the week of 1/22/23 resulting in a dr visit on 1/27/23. Found to have bilateral pulmonary embolii on cat scan. Admitted to hospital for 3 days for heparin therapy and followup echocardiogram and doppler studies. No history of recent travel, surgery or injury. Found to have a DVT behind left knee on Dopler studies. Discharged on Eliquis with outpatient followup
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram, Electrocardiogram, Full blood count, Metabolic function test
Clinical narrative: Developed shortness of breath  and low oxygen saturation the week of 1/22/23 resulting in a dr visit on 1/27/23. Found to have bilateral pulmonary embolii on cat scan. Admitted to hospital for 3 days for heparin therapy and followup echocardiogram and doppler studies. No history of recent travel, surgery or injury. Found to have a DVT behind left knee on Dopler studies. Discharged on Eliquis with outpatient followup
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Pulmonary embolism, Tumour marker test, Ultrasound Doppler abnormal
Clinical narrative: Developed shortness of breath  and low oxygen saturation the week of 1/22/23 resulting in a dr visit on 1/27/23. Found to have bilateral pulmonary embolii on cat scan. Admitted to hospital for 3 days for heparin therapy and followup echocardiogram and doppler studies. No history of recent travel, surgery or injury. Found to have a DVT behind left knee on Dopler studies. Discharged on Eliquis with outpatient followup
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: COVID-19, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: 01/02/23 presents to ED for "fever". PMHx of "HIV/AIDS, hx of syphillis, Hep B chronic infection"
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Hallucinations, mixed, Suspected COVID-19, Swelling
Clinical narrative: SUSPECTED COVID-19 INFECTION; SWELLING OF FACE, EYES AND HANDS; AUDITORY AND VISUAL HALLUCINATIONS; This spontaneous report received from a health care professional via another pharmaceutical company (Pfizer) concerned a 47 year old female. The patient's height, and weight were not reported. The patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported, 1 in total was administered on JUL-2021 for covid-19 prophylaxis. Age at time of vaccination 46 years old. The batch number was not reported and has been requested. Concomitant medications included calcium and Omega 3 (fish oil) for an unknown indication. On an unspecified date, the patient experienced suspected covid-19 infection. The patient was treated with non-company, unspecified suspect drug from Pfizer (form of admin was not reported, route of admin: Oral, batch number: 094351012005 and expiry: Unknown) dose was not reported, administered with two doses 3 pills each from 18-JAN-2023 to 19-JAN-2023 for treatment of covid-19. On 18-JAN-2023:22:00 the patient experienced auditory and visual hallucinations, headaches, throat hurting, trouble breathing, SOB (Shortness of breath), chest hurting and swelling of face, eyes and hands. The patient denies any rash or perioral swelling. Swelling of face, eyes and hands were still present a little at the time of reporting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable and with unspecified non-company suspect drug was not reported. The patient was recovering from auditory and visual hallucinations, and swelling of face, eyes and hands, and the outcome of suspected covid-19 infection was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20230162279- auditory and visual hallucinations. The event shows an incompatible temporal relationship. Therefore, this event is considered inconsistent with vaccine administration.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, Injection site haemorrhage
Clinical narrative: Client presented to Covid Vaccination Site for a first dose on Pfizer COVID infant vaccine, accompanied by his mother. At approximately 1630 client was held in mother?s lap ready for vaccination. When the needle was introduced into the injection site (right deltoid) by nurse, the client suddenly moved causing withdrawal of the needle from injection site. Per nurse the client was properly stabilized by the mother but client was able to move when needle was introduced to site. Per nurse  there was no vaccine pushed out of syringe. To ensure that no vaccine had been administered to the client, the dosage of the syringe was verified by both nurse and lead nurse. The vaccine was still filled with 0.2ml of Pfizer COVID infant vaccine. The syringe and the used needle were disposed of to the appropriate sharps container. The vaccine was wasted and recorded appropriately. The injection site was assessed by both nurse  and lead nurse. There was no bruising and/or redness observed. A drop of blood was observed from injection site. Lead nurse educated client?s parents that the syringe remained with 0.2ml of COVID vaccine and that a second nurse had also checked dosage in syringe.  Lead nurse also educated parents that there was no visible bruising, redness, scratches on injection site. Parents verbalized understanding.  At approximately 1634 client was administered Pfizer COVID infant vaccine Lot#FX5095 first dose by nurse in right arm an inch apart from first attempt. Client and client?s parents proceeded to the observation for a 15-minute observation before departure.  Lead nurse educated client?s parents about the possible side effects of the vaccine and when to seek medical care. An fact sheet for Pfizer Infant in Unknown version was also provided to the client?s parents. Parents verbalized understanding. Client remained in the observation area for the 15 minutes and no signs and symptoms were reported. Client left the facility with a steady gait accompanied by parents.  Lead nurse educated nurse on ways to prevent the same type of incident from happening again and was encouraged to educate parents on the need for and importance of proper stabilization of children. Nurse  verbalized understanding. At approximately 1740 a medical consult was done via text message to doctor to notify of incident and to advise if any further action is needed, doctor replied with, ?No sounds good.?
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Pt had received 3 doses of Pfizer 6mo-4yr COVID vaccines, which completed their COVID vaccine series. A Moderna 6mo-5yr bivalent booster was incorrectly ordered for this pt. A monovalent dose of Moderna 6mo-5yr COVID vaccine was given. Pt mother was notified by office medical director. As of today, pt is currently well with no signs or symptoms of reaction. Staff re-education on COVID vaccination has been addressed.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient got COVID-19 Vaccines when he was 17y
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered, No adverse event
Clinical narrative: pt received a second bivalent pfizer dose. The first on 9/23/22 and the second on 01/30/23.  No side effects reported. Pt just received a second bivalent dose
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood gases abnormal, Blood pH decreased, COVID-19, Chest X-ray abnormal
Clinical narrative: Patient is a 55 y.o. male patient with history of stage IVa adenocarcinoma of the right upper lung, Recurrent and metastatic squamous cell carcinoma involving right neck cancer status postradiation and chemotherapy with extensive history of tobacco abuse actively smoking and history of chronic obstructive pulmonary disease prior history of melanoma and previously treated for pneumonia, and anxiety disorder and hypothyroidism, adrenal insufficiency on glucocorticoid replacement therapy taking Cortef is here due to worsening shortness of breath and change mental status appeared to be in respiratory distress required intubation and vent support on arrival, hypotensive with systolic blood pressure in the 90s ABG with pH of 7.2 and PCO2 of 70, chest x-ray with a pneumonic infiltrates in right lung, required fluid resuscitation and pressors support, leukocytosis at 13,000  Community-acquired pneumonia Acute hypoxic and hypercapnic respiratory failure Chronic obstructive pulm disease in exacerbation Extubated on 1/3 Weaned to nasal cannula.  Remains on nasal cannula today 2L Continue bronchodilators, antibiotics Follow-up cultures, sputum cultures COVID positive.  Flu negative Infectious disease following-continue antibiotics per ID.  Will transition to oral antibiotics on discharge Status post critical care eval Stable for discharge today with close outpatient follow-up.  We will continue O2 support on discharge   Covid-19 Virus Infection Date of onset of symptoms: 12/31 Symptoms present on admission: sob Date of covid positive test: 1/1 Imaging: cxr  Oxygen requirements on admission: vent Current oxygen requirements: Nasal cannula Medical therapy: steroids Consultants following: pulm, ID following Stable for discharge       History of  stage IVa adenocarcinoma of the right upper lung, Recurrent and metastatic squamous cell carcinoma involving right neck cancer status postradiation and chemotherapy Head neck cancer: Concurrent cisplatin-based chemo RT started 9/16/2020, completion date 11/2/20 (completed 6,996 cGy in 33 fractions) Non-small cell lung cancer: Carboplatin / Taxol weekly with concurrent radiation (completed 2/22/21)  Durvalumab q2wk started 3/5/21 therapy stopped due to adverse effects   Recurrent squamous cell carcinoma involving right neck Radiation therapy, 4000 cGy delivered 12/22/2021 Weekly cetuximab started 1/6/2022 -stopped 5/5/2022 due to intolerable skin toxicity   Palliative care consult notes reviewed Oncology follow-up as outpatient
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated, Culture, Dyspnoea, Endotracheal intubation
Clinical narrative: Patient is a 55 y.o. male patient with history of stage IVa adenocarcinoma of the right upper lung, Recurrent and metastatic squamous cell carcinoma involving right neck cancer status postradiation and chemotherapy with extensive history of tobacco abuse actively smoking and history of chronic obstructive pulmonary disease prior history of melanoma and previously treated for pneumonia, and anxiety disorder and hypothyroidism, adrenal insufficiency on glucocorticoid replacement therapy taking Cortef is here due to worsening shortness of breath and change mental status appeared to be in respiratory distress required intubation and vent support on arrival, hypotensive with systolic blood pressure in the 90s ABG with pH of 7.2 and PCO2 of 70, chest x-ray with a pneumonic infiltrates in right lung, required fluid resuscitation and pressors support, leukocytosis at 13,000  Community-acquired pneumonia Acute hypoxic and hypercapnic respiratory failure Chronic obstructive pulm disease in exacerbation Extubated on 1/3 Weaned to nasal cannula.  Remains on nasal cannula today 2L Continue bronchodilators, antibiotics Follow-up cultures, sputum cultures COVID positive.  Flu negative Infectious disease following-continue antibiotics per ID.  Will transition to oral antibiotics on discharge Status post critical care eval Stable for discharge today with close outpatient follow-up.  We will continue O2 support on discharge   Covid-19 Virus Infection Date of onset of symptoms: 12/31 Symptoms present on admission: sob Date of covid positive test: 1/1 Imaging: cxr  Oxygen requirements on admission: vent Current oxygen requirements: Nasal cannula Medical therapy: steroids Consultants following: pulm, ID following Stable for discharge       History of  stage IVa adenocarcinoma of the right upper lung, Recurrent and metastatic squamous cell carcinoma involving right neck cancer status postradiation and chemotherapy Head neck cancer: Concurrent cisplatin-based chemo RT started 9/16/2020, completion date 11/2/20 (completed 6,996 cGy in 33 fractions) Non-small cell lung cancer: Carboplatin / Taxol weekly with concurrent radiation (completed 2/22/21)  Durvalumab q2wk started 3/5/21 therapy stopped due to adverse effects   Recurrent squamous cell carcinoma involving right neck Radiation therapy, 4000 cGy delivered 12/22/2021 Weekly cetuximab started 1/6/2022 -stopped 5/5/2022 due to intolerable skin toxicity   Palliative care consult notes reviewed Oncology follow-up as outpatient
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Influenza virus test negative, Leukocytosis, Lung infiltration, Mental status changes
Clinical narrative: Patient is a 55 y.o. male patient with history of stage IVa adenocarcinoma of the right upper lung, Recurrent and metastatic squamous cell carcinoma involving right neck cancer status postradiation and chemotherapy with extensive history of tobacco abuse actively smoking and history of chronic obstructive pulmonary disease prior history of melanoma and previously treated for pneumonia, and anxiety disorder and hypothyroidism, adrenal insufficiency on glucocorticoid replacement therapy taking Cortef is here due to worsening shortness of breath and change mental status appeared to be in respiratory distress required intubation and vent support on arrival, hypotensive with systolic blood pressure in the 90s ABG with pH of 7.2 and PCO2 of 70, chest x-ray with a pneumonic infiltrates in right lung, required fluid resuscitation and pressors support, leukocytosis at 13,000  Community-acquired pneumonia Acute hypoxic and hypercapnic respiratory failure Chronic obstructive pulm disease in exacerbation Extubated on 1/3 Weaned to nasal cannula.  Remains on nasal cannula today 2L Continue bronchodilators, antibiotics Follow-up cultures, sputum cultures COVID positive.  Flu negative Infectious disease following-continue antibiotics per ID.  Will transition to oral antibiotics on discharge Status post critical care eval Stable for discharge today with close outpatient follow-up.  We will continue O2 support on discharge   Covid-19 Virus Infection Date of onset of symptoms: 12/31 Symptoms present on admission: sob Date of covid positive test: 1/1 Imaging: cxr  Oxygen requirements on admission: vent Current oxygen requirements: Nasal cannula Medical therapy: steroids Consultants following: pulm, ID following Stable for discharge       History of  stage IVa adenocarcinoma of the right upper lung, Recurrent and metastatic squamous cell carcinoma involving right neck cancer status postradiation and chemotherapy Head neck cancer: Concurrent cisplatin-based chemo RT started 9/16/2020, completion date 11/2/20 (completed 6,996 cGy in 33 fractions) Non-small cell lung cancer: Carboplatin / Taxol weekly with concurrent radiation (completed 2/22/21)  Durvalumab q2wk started 3/5/21 therapy stopped due to adverse effects   Recurrent squamous cell carcinoma involving right neck Radiation therapy, 4000 cGy delivered 12/22/2021 Weekly cetuximab started 1/6/2022 -stopped 5/5/2022 due to intolerable skin toxicity   Palliative care consult notes reviewed Oncology follow-up as outpatient
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: PCO2 increased, Pneumonia, Respiratory distress, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Patient is a 55 y.o. male patient with history of stage IVa adenocarcinoma of the right upper lung, Recurrent and metastatic squamous cell carcinoma involving right neck cancer status postradiation and chemotherapy with extensive history of tobacco abuse actively smoking and history of chronic obstructive pulmonary disease prior history of melanoma and previously treated for pneumonia, and anxiety disorder and hypothyroidism, adrenal insufficiency on glucocorticoid replacement therapy taking Cortef is here due to worsening shortness of breath and change mental status appeared to be in respiratory distress required intubation and vent support on arrival, hypotensive with systolic blood pressure in the 90s ABG with pH of 7.2 and PCO2 of 70, chest x-ray with a pneumonic infiltrates in right lung, required fluid resuscitation and pressors support, leukocytosis at 13,000  Community-acquired pneumonia Acute hypoxic and hypercapnic respiratory failure Chronic obstructive pulm disease in exacerbation Extubated on 1/3 Weaned to nasal cannula.  Remains on nasal cannula today 2L Continue bronchodilators, antibiotics Follow-up cultures, sputum cultures COVID positive.  Flu negative Infectious disease following-continue antibiotics per ID.  Will transition to oral antibiotics on discharge Status post critical care eval Stable for discharge today with close outpatient follow-up.  We will continue O2 support on discharge   Covid-19 Virus Infection Date of onset of symptoms: 12/31 Symptoms present on admission: sob Date of covid positive test: 1/1 Imaging: cxr  Oxygen requirements on admission: vent Current oxygen requirements: Nasal cannula Medical therapy: steroids Consultants following: pulm, ID following Stable for discharge       History of  stage IVa adenocarcinoma of the right upper lung, Recurrent and metastatic squamous cell carcinoma involving right neck cancer status postradiation and chemotherapy Head neck cancer: Concurrent cisplatin-based chemo RT started 9/16/2020, completion date 11/2/20 (completed 6,996 cGy in 33 fractions) Non-small cell lung cancer: Carboplatin / Taxol weekly with concurrent radiation (completed 2/22/21)  Durvalumab q2wk started 3/5/21 therapy stopped due to adverse effects   Recurrent squamous cell carcinoma involving right neck Radiation therapy, 4000 cGy delivered 12/22/2021 Weekly cetuximab started 1/6/2022 -stopped 5/5/2022 due to intolerable skin toxicity   Palliative care consult notes reviewed Oncology follow-up as outpatient
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Sputum culture, White blood cell count increased
Clinical narrative: Patient is a 55 y.o. male patient with history of stage IVa adenocarcinoma of the right upper lung, Recurrent and metastatic squamous cell carcinoma involving right neck cancer status postradiation and chemotherapy with extensive history of tobacco abuse actively smoking and history of chronic obstructive pulmonary disease prior history of melanoma and previously treated for pneumonia, and anxiety disorder and hypothyroidism, adrenal insufficiency on glucocorticoid replacement therapy taking Cortef is here due to worsening shortness of breath and change mental status appeared to be in respiratory distress required intubation and vent support on arrival, hypotensive with systolic blood pressure in the 90s ABG with pH of 7.2 and PCO2 of 70, chest x-ray with a pneumonic infiltrates in right lung, required fluid resuscitation and pressors support, leukocytosis at 13,000  Community-acquired pneumonia Acute hypoxic and hypercapnic respiratory failure Chronic obstructive pulm disease in exacerbation Extubated on 1/3 Weaned to nasal cannula.  Remains on nasal cannula today 2L Continue bronchodilators, antibiotics Follow-up cultures, sputum cultures COVID positive.  Flu negative Infectious disease following-continue antibiotics per ID.  Will transition to oral antibiotics on discharge Status post critical care eval Stable for discharge today with close outpatient follow-up.  We will continue O2 support on discharge   Covid-19 Virus Infection Date of onset of symptoms: 12/31 Symptoms present on admission: sob Date of covid positive test: 1/1 Imaging: cxr  Oxygen requirements on admission: vent Current oxygen requirements: Nasal cannula Medical therapy: steroids Consultants following: pulm, ID following Stable for discharge       History of  stage IVa adenocarcinoma of the right upper lung, Recurrent and metastatic squamous cell carcinoma involving right neck cancer status postradiation and chemotherapy Head neck cancer: Concurrent cisplatin-based chemo RT started 9/16/2020, completion date 11/2/20 (completed 6,996 cGy in 33 fractions) Non-small cell lung cancer: Carboplatin / Taxol weekly with concurrent radiation (completed 2/22/21)  Durvalumab q2wk started 3/5/21 therapy stopped due to adverse effects   Recurrent squamous cell carcinoma involving right neck Radiation therapy, 4000 cGy delivered 12/22/2021 Weekly cetuximab started 1/6/2022 -stopped 5/5/2022 due to intolerable skin toxicity   Palliative care consult notes reviewed Oncology follow-up as outpatient
Age: 63.0
Sex: M
Vaccine: TDAP
Symptoms: Product administration error, Wrong product administered
Clinical narrative: TDap given in error. Patient was to receive famotidine but was given tdap iv in error.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Flank pain, Haematuria, Myalgia
Clinical narrative: Gross hematuria and right flank pain, myalgias (generalized
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Disorientation, Feeling abnormal, Inflammation
Clinical narrative: Brain fog: disorientation, inability to process or remember verbal directions, intermittent blackout for several days following second dose. Joint Pain, ongoing and still an issue Inflammation of arms and hands, ongoing. Still an issue.  Overall not feeling well: Chills, fever, aches for two days following first dose.  Sleeplessness, beginning to resolve at 22 months following vaccination
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Insomnia, Loss of consciousness, Malaise, Memory impairment, Pain
Clinical narrative: Brain fog: disorientation, inability to process or remember verbal directions, intermittent blackout for several days following second dose. Joint Pain, ongoing and still an issue Inflammation of arms and hands, ongoing. Still an issue.  Overall not feeling well: Chills, fever, aches for two days following first dose.  Sleeplessness, beginning to resolve at 22 months following vaccination
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Brain fog: disorientation, inability to process or remember verbal directions, intermittent blackout for several days following second dose. Joint Pain, ongoing and still an issue Inflammation of arms and hands, ongoing. Still an issue.  Overall not feeling well: Chills, fever, aches for two days following first dose.  Sleeplessness, beginning to resolve at 22 months following vaccination
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: PATIENT GOT COVID-19 VACCINES WHEN HE WAS 17 Y
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, COVID-19, COVID-19 pneumonia, Death, Dyspnoea
Clinical narrative: to ER with SOB,   had covid and was  ADMITTED ON 10-30-2022 and required intubation.  had h/o addisons disease on chronic hydrocortison, Had resp failure.  paroxysmal afib,   had bacteremia due to enterococcus faecium.  Had covid pneumonia . remdesivir from 10-31 to 11-3;  had linzeolid ,   had zosyn as well.   consults with pulmonology, neurology, dietician, psychiatritry, cardiology, nephrology, infectious disease, hospice referral made for home hospice, general surgery for PEG tube ,  Eventually was able to be dc to home apparently on 12/13/22 DECEASED  12-28-2022
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Endotracheal intubation, Enterococcal bacteraemia, Gastrostomy, Respiratory failure
Clinical narrative: to ER with SOB,   had covid and was  ADMITTED ON 10-30-2022 and required intubation.  had h/o addisons disease on chronic hydrocortison, Had resp failure.  paroxysmal afib,   had bacteremia due to enterococcus faecium.  Had covid pneumonia . remdesivir from 10-31 to 11-3;  had linzeolid ,   had zosyn as well.   consults with pulmonology, neurology, dietician, psychiatritry, cardiology, nephrology, infectious disease, hospice referral made for home hospice, general surgery for PEG tube ,  Eventually was able to be dc to home apparently on 12/13/22 DECEASED  12-28-2022
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Acidosis, Alanine aminotransferase normal, Angiogram normal, Aspartate aminotransferase increased, Blood bilirubin increased
Clinical narrative: 54 y.o. male patient of Physician No with history of esophageal varices (last banding 1 year ago), decompensated alcoholic cirrhosis, hepatitis C and HTN. Transferred from Hospital where he initially presented for large volume hematemesis followed by subsequent cardiac arrest, managed in the ICU eventually transferred to the floor. He left AMA saying he had a rehab place line up. He left despite worsening liver failure and without any appropriate follow ups arranged.        Decompensated Alcoholic Cirrhosis Hepatitis C Unable to verify extent of alcohol use, was previously sober for 9 months in 2020 but unclear if still drinking Home meds: propranolol, spironolactone, Hep C quant and Ab positive 2020, unclear if treated Repeat Hep C quant 605,000 IV thiamine  Encourage cessation, consider addiction med c/s  Rising T bili 0.5-- >2.6,  rising AST 54-- >107, ALT wnl, will re-consult GI Patient wants to leave but parameters heading in the wrong direction. He eventually signed out AMA knowing the risk. He appeared to have capacity.    Cardiac Arrest Suspect 2/2 to hypovolemic shock from esophageal variceal bleeding vs profound acidosis  ROSC obtained after two rounds of CPR, Ca, Epi, and Bicarb S/p 2u pRBC EKG no ischemic changes  Wean sedation and ventilation as tolerated Post cardiac arrest protocol initiated: Target temperature management, CT head pending, EEG Cardio consulted, signed off 12/29 No further testing per cardiology  Neurology consulted, signed off 12/29   Upper GI bleed Acute blood loss on chronic anemia  Esophageal varices, secondary to alcoholic cirrhosis as below  Patient with history of varices, last banding one year ago; now presenting with large volume hematemesis prior to cardiac arrest, see above.  On admission Hgb 11.7, b/l 9.1-10.6 CTA abd/chest/pelvis with no signs of active bleeding  S/p 2U pRBC, protonix bolus On Octreotide gtt, discontinued 12/30 S/p CTX in ED for CAP, see below, will continue for SBP prophylaxis Rocephin and Protonix IV x 5 days  Gastroenterology consulted EGD 12/28 + stigmata of recent esophageal variceal bleed, s/p band x5 IF rebleeds from varices will need VIR for emergent TIPS  Okay from GI for diet  Was tolerating diet prior to discharge.  Acute Hypercapnic respiratory failure Multifocal Pneumonia COVID-19 2/2 cardiac arrest in the setting of acute COVID infection and imaging c/f CAP Currently sedated and on ventilator Continue dilaudid and propofol gtt, added precedex 12/29 as weaning off other medications  Continue Azithro/CTX for CAP coverage Steroids and remdesivir  Legionella and strep pneumo antigen negative  MRSA nares positive  Blood Cx prelim negative Extubated 12/30 on NC  PRN cough suppressants for comfort